Investing Profile

Scott Bluestein

Chief Investment Officer at Hercules Technology Growth Capital

Your Intro Paths to Scott Bluestein

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Scott is a member of

Emory University Network

47 CONNECTIONS

Hercules Capital Network

17 CONNECTIONS

Hercules Capital Network

17 CONNECTIONS

Hercules Capital Network

17 CONNECTIONS

Find Scott Bluestein on

Current Investing Position

Investments On Record

Scott Bluestein's Investments On Record (6)

Company	StageDateRound Size	Total Raised
Semperis	Series CJun 2024$130M	$370M
Co-investors: Teddie Wardi (Insight Partners), Mark Hatfield (Ten Eleven Ventures), Charlie Federman (Silvertech Ventures), Moshe Lichtman (Israel Growth Partners), Rafi Gidron
Tricida	Post Ipo DebtOct 2022$130M	$320M
Co-investors: David Bonita (OrbiMed)
Dermavant Sciences	Debt FinancingMay 2019$20M	$20M
Intuity Medical	Series UnknownJan 2018$70M	$220M
Co-investors: Anders Hove (Acorn Bioventures), Casey Tansey (U.S. Venture Partners (USVP)), Eric Aguiar (Aisling Capital)
Antares Pharma	Post Ipo DebtJun 2017$35M	$35M
Sio Gene Therapies	Post Ipo DebtFeb 2017$55M	$55M

Scott Bluestein's Experience

Chief Investment Officer Hercules Technology Growth Capital2014 - Present

Chief Credit Officer Hercules Technology Growth Capital2010 - Present

Chief Credit Officer Hercules CapitalPresent

Chief Credit Officer Hercules Capital, Inc.Present

Chief Investment Officer Hercules CapitalPresent

Chief Investment Officer Hercules Capital, Inc.Present

Chief Executive Officer and Chief Investment Officer at Hercules Capital Hercules CapitalPresent

Chief Executive Officer and Chief Investment Officer at Hercules Capital Hercules Capital, Inc.Present

Chief Investment Officer Century Tree Capital Management2009 - 2010

Scott Bluestein's Education

Emory University BBA Finance and Political Science

Investors who invest with Scott Bluestein

Scouts & Angels Affiliated With Scott Bluestein